114 related articles for article (PubMed ID: 38076806)
21. Strain and sex-related behavioral variability of oxycodone dependence in rats.
Doyle MR; Martinez AR; Qiao R; Dirik S; Di Ottavio F; Pascasio G; Martin-Fardon R; Benner C; George O; Telese F; de Guglielmo G
Neuropharmacology; 2023 Oct; 237():109635. PubMed ID: 37327971
[TBL] [Abstract][Full Text] [Related]
22. Oral prescription opioid-seeking behavior in male and female mice.
Phillips AG; McGovern DJ; Lee S; Ro K; Huynh DT; Elvig SK; Fegan KN; Root DH
Addict Biol; 2020 Nov; 25(6):e12828. PubMed ID: 31489746
[TBL] [Abstract][Full Text] [Related]
23. Comparing withdrawal- and anxiety-like behaviors following oral and subcutaneous oxycodone administration in C57BL/6 mice.
De Almeida SS; Drinkuth CR; Sartor GC
Behav Pharmacol; 2024 Aug; 35(5):269-279. PubMed ID: 38847447
[TBL] [Abstract][Full Text] [Related]
24. Selective M
Teal LB; Bubser M; Duncan E; Gould RW; Lindsley CW; Jones CK
Neuropharmacology; 2023 Apr; 227():109424. PubMed ID: 36720403
[TBL] [Abstract][Full Text] [Related]
25. Oxycodone self-administration and reinstatement in male and female squirrel monkeys: Effects of alternative reinforcer availability.
de Moura FB; Booth RG; Kohut SJ
bioRxiv; 2023 Jan; ():. PubMed ID: 36711610
[TBL] [Abstract][Full Text] [Related]
26. Sex differences in escalation of methamphetamine self-administration: cognitive and motivational consequences in rats.
Reichel CM; Chan CH; Ghee SM; See RE
Psychopharmacology (Berl); 2012 Oct; 223(4):371-80. PubMed ID: 22592902
[TBL] [Abstract][Full Text] [Related]
27. Oxycodone physical dependence and its oral self-administration in C57BL/6J mice.
Enga RM; Jackson A; Damaj MI; Beardsley PM
Eur J Pharmacol; 2016 Oct; 789():75-80. PubMed ID: 27393461
[TBL] [Abstract][Full Text] [Related]
28. Oxycodone self-administration in male and female rats.
Mavrikaki M; Pravetoni M; Page S; Potter D; Chartoff E
Psychopharmacology (Berl); 2017 Mar; 234(6):977-987. PubMed ID: 28127624
[TBL] [Abstract][Full Text] [Related]
29. Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats.
Kimbrough A; Kononoff J; Simpson S; Kallupi M; Sedighim S; Palomino K; Conlisk D; Momper JD; de Guglielmo G; George O
Psychopharmacology (Berl); 2020 May; 237(5):1545-1555. PubMed ID: 32114633
[TBL] [Abstract][Full Text] [Related]
30. Neuroplasticity-related genes correlate with individual differences in distinct phases of oxycodone self-administration in male rats.
Vassoler FM; Budge KE; Isgate SB; Gildawie KR; Byrnes EM
Neuropharmacology; 2024 Aug; 254():109972. PubMed ID: 38710443
[TBL] [Abstract][Full Text] [Related]
31. Escalation and reinstatement of fentanyl self-administration in male and female rats.
Malone SG; Keller PS; Hammerslag LR; Bardo MT
Psychopharmacology (Berl); 2021 Aug; 238(8):2261-2273. PubMed ID: 33895852
[TBL] [Abstract][Full Text] [Related]
32. The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.
You ZB; Gao JT; Bi GH; He Y; Boateng C; Cao J; Gardner EL; Newman AH; Xi ZX
Neuropharmacology; 2017 Nov; 126():190-199. PubMed ID: 28888944
[TBL] [Abstract][Full Text] [Related]
33. Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats.
Rogers JL; De Santis S; See RE
Psychopharmacology (Berl); 2008 Sep; 199(4):615-24. PubMed ID: 18493748
[TBL] [Abstract][Full Text] [Related]
34. Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats.
Mantsch JR; Baker DA; Francis DM; Katz ES; Hoks MA; Serge JP
Psychopharmacology (Berl); 2008 Jan; 195(4):591-603. PubMed ID: 17899015
[TBL] [Abstract][Full Text] [Related]
35. Oral oxycodone self-administration leads to features of opioid misuse in male and female mice.
Slivicki RA; Earnest T; Chang YH; Pareta R; Casey E; Li JN; Tooley J; Abiraman K; Vachez YM; Wolf DK; Sackey JT; Kumar Pitchai D; Moore T; Gereau RW; Copits BA; Kravitz AV; Creed MC
Addict Biol; 2023 Jan; 28(1):e13253. PubMed ID: 36577735
[TBL] [Abstract][Full Text] [Related]
36. In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.
Bossert JM; Kiyatkin EA; Korah H; Hoots JK; Afzal A; Perekopskiy D; Thomas S; Fredriksson I; Blough BE; Negus SS; Epstein DH; Shaham Y
Biol Psychiatry; 2020 Dec; 88(12):935-944. PubMed ID: 32305216
[TBL] [Abstract][Full Text] [Related]
37. Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.
Leri F; Burns LH
Pharmacol Biochem Behav; 2005 Oct; 82(2):252-62. PubMed ID: 16182352
[TBL] [Abstract][Full Text] [Related]
38. Relapse-like behavior in a mouse model of the OPRM1 (mu-opioid receptor) A118G polymorphism: Examination with intravenous oxycodone self-administration.
Zhang Y; Collins D; Butelman ER; Blendy JA; Kreek MJ
Neuropharmacology; 2020 Dec; 181():108351. PubMed ID: 33031806
[TBL] [Abstract][Full Text] [Related]
39. Who is HOT and who is LOT? Detailed characterization of prescription opioid-induced changes in behavior between 129P3/J and 129S1/SvlmJ mouse substrains.
Szumlinski KK; Coelho MA; Tran T; Stailey N; Lieberman D; Gabriella I; Swauncy I; Brewin LW; Ferdousian S
Genes Brain Behav; 2020 Jun; 19(5):e12609. PubMed ID: 31489753
[TBL] [Abstract][Full Text] [Related]
40. Prophylactic vaccination protects against the development of oxycodone self-administration.
Nguyen JD; Hwang CS; Grant Y; Janda KD; Taffe MA
Neuropharmacology; 2018 Aug; 138():292-303. PubMed ID: 29936242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
